Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial

Nephrology ◽  
2019 ◽  
Vol 2_2019 ◽  
pp. 6-15
Author(s):  
V.IU. Shilo Shilo ◽  
L.I. Alihanova Alihanova ◽  
V.P. Babich Babich ◽  
K.A. Vishnevskii Vishnevskii ◽  
I.V. Zhdanova Zhdanova ◽  
...  
2002 ◽  
Vol 21 (12) ◽  
pp. 1711-1726 ◽  
Author(s):  
Seth M. Steinberg ◽  
David J. Venzon

Oncotarget ◽  
2017 ◽  
Vol 8 (51) ◽  
pp. 88376-88385
Author(s):  
Dung-Tsa Chen ◽  
Po-Yu Huang ◽  
Hui-Yi Lin ◽  
Alberto A. Chiappori ◽  
Dmitry I. Gabrilovich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document